Literature DB >> 9064331

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.

S L Peng1, M E Robert, A C Hayday, J Craft.   

Abstract

Fas (CD95) and its ligand are central regulatory molecules in hematopoietic cells. Previous studies have suggested a role for Fas in the regulation of tumor progression, but Fas has not yet been conclusively identified as a tumor suppressor. Fas-deficient individuals lack malignant tumors, perhaps because of regulation by T cells. To investigate such a possibility, mice deficient in both T cells and Fas were generated, and they were found to develop severe B cell dysregulation characterized by malignant, lethal B cell lymphoma. Lymphoma arose from a monoclonal B220+CD19-CD5-CD23- B cell secreting immunoglobulin M, kappa rheumatoid factor. In contrast, animals containing alpha beta T cells, gamma delta T cells, and/or functional Fas suppressed the development of lymphoma. These data indicate that Fas functions as a tumor suppressor, and identifies roles for both alpha beta T cells and gamma delta T cells in Fas-independent tumor regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9064331      PMCID: PMC2192794          DOI: 10.1084/jem.184.3.1149

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Murine lupus in the absence of alpha beta T cells.

Authors:  S L Peng; M P Madaio; D P Hughes; I N Crispe; M J Owen; L Wen; A C Hayday; J Craft
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

2.  The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance.

Authors:  L Van Parijs; A Ibraghimov; A K Abbas
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

3.  Functional significance of the Fas molecule in naive lymphocytes.

Authors:  S Senju; I Negishi; N Motoyama; F Wang; K Nakayama; K Nakayama; P J Lucas; S Hatakeyama; Q Zhang; S Yonehara; D Y Loh
Journal:  Int Immunol       Date:  1996-03       Impact factor: 4.823

4.  Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.

Authors:  T Tamura; N Aoyama; H Saya; H Haga; S Futami; M Miyamoto; T Koh; T Ariyasu; M Tachi; M Kasuga
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

5.  Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma.

Authors:  S L Speaks; W G Sanger; A S Masih; D S Harrington; M Hess; J O Armitage
Journal:  Genes Chromosomes Cancer       Date:  1992-10       Impact factor: 5.006

6.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.

Authors:  H C Morse; W F Davidson; R A Yetter; E D Murphy; J B Roths; R L Coffman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.

Authors:  M C Nussenzweig; E V Schmidt; A C Shaw; E Sinn; J Campos-Torres; B Mathey-Prevot; P K Pattengale; P Leder
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

8.  Loss of the chromosomal region 10q23-25 in prostate cancer.

Authors:  I C Gray; S M Phillips; S J Lee; J P Neoptolemos; J Weissenbach; N K Spurr
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr.

Authors:  H C Morse; J B Roths; W F Davidson; W Y Langdon; T N Fredrickson; J W Hartley
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  28 in total

1.  Resistance to apoptosis induced by microenvironmental stresses is correlated with metastatic potential in Lewis lung carcinoma.

Authors:  M Takasu; Y Tada; J O Wang; M Tagawa; K Takenaga
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 2.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 3.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

4.  Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.

Authors:  Sudha Neelam; Jessamee Mellon; Amber Wilkerson; Jerry Y Niederkorn
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

Review 5.  The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

6.  Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR.

Authors:  G Blank; C Welker; J Haarer; M Sterk; S Nadalin; V A C Yañez; T O Joos; A Menrad; D Snell; G LaCorcia; A Königsrainer; R Handgretinger; K Schilbach
Journal:  Bone Marrow Transplant       Date:  2014-11-17       Impact factor: 5.483

Review 7.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

8.  Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy.

Authors:  K Newton; A Strasser
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

9.  Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.

Authors:  Isaac Engel; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

10.  Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice.

Authors:  Christopher L Hall; Mike Yao; Laurie L Hill; Laurie B Owen-Schaub
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.